The Reference-scaled Average Bioequivalence (RSABE) Approach Blog The Reference-scaled Average Bioequivalence (RSABE) Approach We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…CertaraJuly 1, 2025
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…CertaraJune 30, 2025
Maintain & Adapt Pharma Market Access Digital Tools Using Feedback Blog Maintain & Adapt Pharma Market Access Digital Tools Using Feedback Maintain the credibility of your pharma market access digital tools through continuous updates based on…CertaraJune 30, 2025
Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power Announcement Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power June 16, 2025 RADNOR, PA – June 16, 2025 – Certara, Inc. (Nasdaq: CERT), a…CertaraJune 16, 2025
Certara Reports First Quarter 2025 Financial Results Press Release Certara Reports First Quarter 2025 Financial Results RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…CertaraMay 5, 2025
Best Practices for AI Prompt Engineering in Life Sciences Blog Best Practices for AI Prompt Engineering in Life Sciences April 23, 2025 Prompt engineering is an emerging skill introduced to the public with the…CertaraApril 23, 2025
Certara Announces Second Annual Certainty U.S. Event Announcement Certara Announces Second Annual Certainty U.S. Event Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…CertaraApril 22, 2025
How to Use Fix Tips for Better Clinical Data Issue Management Blog How to Use Fix Tips for Better Clinical Data Issue Management April 15, 2025 Prior to submission to any regulatory agency, standardized study data is evaluated using at…CertaraApril 15, 2025